$NRIX

$25.55 +$0.21 (0.83%) Close

$NRIX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 109.2M shares outstanding

Who owns NRIX?

By type of holder

Institutions 100.0% Insiders 0.0% Everyone else 0.0%

Concentration Top 10 holders own 55.7%

BlackRock, Inc. 8.0% · Vestal Point Capital, LP 7.4%

Institutional ownership

100.0%

0 pts vs last qtr

Institutional holders

208

+12 vs last qtr

Net shares bought

+8.0K

by institutions in Q2 2026

New / sold out

45 / 33

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Rubric Capital Management LP +4.8M
Price T Rowe Associates Inc /MD/ +2.1M

Biggest sellers in Q2 2026

Redmile Group, LLC −3.7M
Commodore Capital LP SOLD OUT −2.3M

Who is planning to sell?

Notices of proposed sale, last 12 months

$4.5M

20 notices from 5 people

Shares covered

231.4K

0.21% of the company

Arranged in advance

88%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Christine Ring Officer 10b5-1 $3.12M
Julia Gregory Director $529K

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2021–FY2025

+102.0%

+19.22% a year

Each share's claim on the business

−50.5%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $149M

over 5 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years46% 3–5 years13% 1–3 years21% Under 1 year20%

Quarterly turnover

15.6%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting NRIX on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B BlackRock, Inc.	8.8M	8.03%	−155.3K (−1.7%)	≤2021	0.0%
Shares held by quarter Peak holding8.9M (Q1'26) Change over 8 quarters+1.6M Share of the company8.030% BlackRock, Inc.'s full portfolio →
VP Vestal Point Capital, LP	8.1M	7.37%	+1.6M (+23.8%)	2024	4.6%
Shares held by quarter Peak holding8.1M (Q2'26) Change over 8 quarters+7.6M Share of the company7.370% Vestal Point Capital, LP's full portfolio →

BlackRock, Inc.

8.8M

% of company

8.03%

Change vs last qtr

−155.3K (−1.7%)

Held since

≤2021

Vestal Point Capital, LP

8.1M

% of company

7.37%

Change vs last qtr

+1.6M (+23.8%)

Held since

2024

28 more super investors behind a free account

See every manager holding Nurix Therapeutics, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting NRIX on Form N-PORT; together they hold 30.7% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$79.4M	3.3M	3.00%	0.00%	June 30, 2026
IR iShares Russell 2000 ETF iShares Trust	$60.8M	2.5M	2.29%	0.07%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$79.4M

% of company

3.00%

% of the fund

0.00%

As of

June 30, 2026

iShares Russell 2000 ETF

iShares Trust

Position value

$60.8M

% of company

2.29%

% of the fund

0.07%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Nurix Therapeutics, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
HG Hansen Gwenn Insider	117.2K	0.11%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.110% Hansen Gwenn's insider activity →
VH van Houte Hans Insider	40.2K	0.04%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.040% van Houte Hans's insider activity →

Hansen Gwenn

Insider

117.2K

% of company

0.11%

Change vs last qtr

—

Held since

—

van Houte Hans

Insider

40.2K

% of company

0.04%

Change vs last qtr

—

Held since

—

2 more holders behind a free account

See every insider and 5%+ holder of Nurix Therapeutics, Inc..

Comments